New genomic tools improve detection of rare DNA changes
WashU Medicine researchers have verified the accuracy of genetics tools to correctly identify all the rare DNA changes…
A catalog of transcriptome genetic regulation in a consanguineous Middle Eastern biobank
Dehghan, M. et al. Association of dairy intake with cardiovascular disease and mortality in 21 countries from five…
DNA Typewriter tracks cell divisions and developmental decisions in mice
Scientists have succeeded in reconstructing the family tree of cells in a developing mouse embryo. They recorded cells’…
An AI-identified biomarker can look accurate and still fail its biggest test
From blood samples to scans and wearables, the review follows what happens after an AI model identifies a…
UCLA researchers present new radiation advances at ASTRO 2026
Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share new research and clinical trial…
Blood protein profiling could improve rare disease diagnosis
Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England…
Caloric restriction reduces genetic mutations across the mouse genome
Mutations are changes in the molecular “letters” that make up DNA, the genetic blueprint for cells. Mutations build…
New study uncovers bacterial route to testosterone production
Many prostate cancers depend on androgen hormones, including testosterone, to grow. That is why treatments for advanced disease…
Multi-ancestry genetic score improves risk prediction for Alzheimer’s disease
Late-onset Alzheimer disease (AD) is a progressive disorder characterized by cognitive decline and memory impairment, affecting an estimated…
Deliverome project maps cell surface proteins for better drug delivery
For a new drug to work in the human body, it must make its way to the exact…
Molecular mapping reveals hidden cellular programs in heart transplant rejection
A new study that explores gene expression during heart transplant rejection marks a step forward for precision medicine…
New protein blueprint opens door for targeted Parkinson’s disease therapies
Researchers at Weill Cornell Medicine have uncovered how a key Parkinson’s protein called LRRK2 shifts between inactive and…